Clinical Trial Update: Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating REOLYSIN in combination with paclitaxel and carboplatin in metastatic melanoma that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED